Korman N, Passeron T, Gordon K, Okubo Y, Bagel J, Sofen H, Warren R, Bhatia N, Spelman L, Winthrop K, Hippeli L, Kisa R, Banerjee S, Thaçi D. Deucravacitinib in plaque psoriasis: 2-year laboratory results from the phase 3 POETYK PSO program. J of Skin [Internet]. 2022 Nov. 16 [cited 2024 Jul. 3];6(6):s46. Available from: https://jofskin.org/33014/index.php/skin/article/view/1801